Short-term FSH treatment and sperm maturation: a prospective study in idiopathic infertile men

Andrology

Volumn 5, Issue 3, 2017, Pages 414-422

  Casamonti, E ^a   Vinci, S ^a   Serra, E ^a   Fino, M G ^a   Brilli, S ^a   Lotti, F ^a   Maggi, M ^a   Coccia, M E ^a   Forti, G ^a   Krausz, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

FSH therapy; male infertility; pharmacogenetics; sperm hyaluronic acid binding; spermatogenesis

Indexed keywords

HYALURONIC ACID; PLACEBO; UROFOLLITROPIN; CARRIER PROTEIN; FOLLITROPIN; FOLLITROPIN RECEPTOR; FSH-BI PROTEIN, HUMAN; GLYCOPEPTIDE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON MATURATION; SPERMATOZOON MOTILITY; TESTIS SIZE; CLINICAL TRIAL; DRUG EFFECTS; GENETICS; INFERTILITY, MALE; SPERMATOZOON;

CARRIER PROTEINS; FOLLICLE STIMULATING HORMONE; GENOTYPE; GLYCOPEPTIDES; HUMANS; INFERTILITY, MALE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, FSH; SPERM MATURATION; SPERMATOZOA;

EID: 85015301139     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/andr.12333     Document Type: Article

References (46)

1. Attia AM, Abou-Setta AM & Al-Inany HG. (2013) Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 25.
2. Baccetti B, Strehler E, Capitani S, Collodel G, De Santo M, Moretti E, Piomboni P, Wiedeman R & Sterzik K. (1997) The effect of follicle stimulating hormone therapy on human sperm structure (Notulae seminologicae 11). Hum Reprod 12, 1955–1968.
3. Baccetti B, Piomboni P, Bruni E, Capitani S, Gambera L, Moretti E, Sterzik K & Strehler E. (2004) Effect of follicle-stimulating hormone on sperm quality and pregnancy rate. Asian J Androl 6, 133–137.
4. Bartoov B, Eltes F, Lunenfeld E, Har-Even D, Lederman H & Lunenfeld B. (1994) Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil Steril 61, 727–734.
5. Ben-Rafael Z, Farhi J, Feldberg D, Bartoov B, Kovo M, Eltes F & Ashkenazi J. (2000) Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil Steril 73, 24–30.
6. Busch AS, Kliesch S, Tüttelmann F & Gromoll J. (2015) FSHB −211G>T stratification for follicle-stimulating hormone treatment of male infertility patients: making the case for a pharmacogenetic approach in genetic functional secondary hypogonadism. Andrology 3, 1050–1053.
7. Cayli S, Jakab A, Ovari L, Delpiano E, Celik-Ozenci C, Sakkas D, Ward D & Huszar G. (2003) Biochemical markers of sperm function: male fertility and sperm selection for ICSI. Reprod Biomed Online 7, 462–468.
8. Colacurci N, Monti MG, Fornaro F, Izzo G, Izzo P, Trotta C, Mele D & De Franciscis P. (2012) Recombinant human FSH reduces sperm DNA fragmentation in men with idiopathic oligoasthenoteratozoospermia. J Androl 33, 588–593.
9. Ferlin A, Vinanzi C, Selice R, Garolla A, Frigo AC & Foresta C. (2011) Toward a pharmacogenetics approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter. Fertil Steril 96, 1344–1349.
10. Foresta C, Bettella A, Merico M, Garolla A, Plebani M, Ferlin A & Rossato M. (2000) FSH in the treatment of oligozoospermia. Mol Cell Endocrinol 161, 89–97.
11. Foresta C, Bettella A, Merico M, Garolla A, Ferlin A & Rossato M. (2002) Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril 77, 238–244.
12. Foresta C, Bettella A, Garolla A, Ambrosini G & Ferlin A. (2005) Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril 84, 654–661.
13. Glander HJ & Kratzsch J. (1997) Effects of pure human follicle-stimulating hormone (pFSH) on sperm quality correlate with the hypophyseal response to gonadotrophin-releasing hormone (GnRH). Andrologia 29, 23-28.
14. Grigorova M, Punab M, Ausmees K & Laan M. (2008) FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Hum Reprod 23, 2160–2166.
15. Grigorova M, Punab M, Poolamets O, Kelgo P, Ausmees K, Korrovits P, Vihljajev V & Laan M. (2010) Increased prevalance of the −211 T allele of follicle stimulating hormone (FSH) beta subunit promoter polymorphism and lower serum FSH in infertile men. J Clin Endocrinol Metab 95, 100–108.
16. Grigorova M, Punab M, Zilaitien≐ B, Erenpreiss J, Ausmees K, Matuleviĉius V, Tsarev I, Jørgensen N & Laan M. (2011) Genetically determined dosage of follicle-stimulating hormone (FSH) affects male reproductive parameters. J Clin Endocrinol Metab 96, E1534–E1541.
17. Grigorova M, Punab M, Poolamets O, Sõber S, Vihljajev V, Žilaitien≐ B, Erenpreiss J, Matulevičius V, Tsarev I & Laan M. (2013) Study in 1790 Baltic men: FSHR Asn680Ser polymorphism affects total testes volume. Andrology 1, 293–300.
18. Grigorova M, Punab M, Punab AM, Poolamets O, Vihljajev V, Zilaitien≐ B, Erenpreiss J, Matulevičius V & Laan M. (2014) Reproductive physiology in young men is cumulatively affected by FSH-action modulating genetic variants: FSHR −29G/A and c.2039 A/G, FSHB −211G/T. PLoS ONE 9, e94244.
19. Huszar G, Stone K, Dix D & Vigue L. (2000) Putative creatine kinase M-isoform in human sperm is identified as the 70-kilodalton heat shock protein HspA2. Biol Reprod 63, 925–932.
20. Huszar G, Jakab A, Sakkas D, Ozenci CC, Cayli S, Delpiano E & Ozkavukcu S. (2002) Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects. Reprod Biomed Online 14, 650–663.
21. Huszar G, Ozenci CC, Cayli S, Zavaczki Z, Hansch E & Vigue L. (2003) Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status. Fertil Steril 79(Suppl. 3), 1616–1624.
22. Huszar G, Jakab A, Sakkas D, Ozenci CC, Cayli S, Delpiano E & Ozkavukcu S. (2007) Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects. Reprod Biomed Online 14, 650–663.
23. Jakab A, Sakkas D, Delpiano E, Cayli S, Kovanci E, Ward D, Revelli A & Huszar G. (2005) Intracytoplasmic sperm injection: a novel selection method for sperm with normal frequency of chromosomal aneuploidies. Fertil Steril 84, 1665–1673.
24. Kamischke A, Behre HM, Bergmann M, Simoni M, Schäfer T & Nieschlag E. (1998) Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 13, 596–603.
25. Kovacs P, Kovats T, Sajgo A, Szollosi J, Matyas S & Kaali SG. (2011) The role of hyaluronic acid binding assay in choosing the fertilization method for patients undergoing IVF for unexplained infertility. J Assist Reprod Genet 28, 49–54.
26. Krausz C. (2011) Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab 25, 271–285.
27. Krishnamurthy H, Danilovich N, Morales CR & Sairam MR. (2000) Qualitative and quantitative decline in spermatogenesis of the follicle-stimulating hormone receptor knockout (FORKO) mouse. Biol Reprod 62, 1146–1159.
28. Mokánszki A, Molnár Z, Ujfalusi A, Balogh E, Bazsáné ZK, Varga A, Jakab A & Oláh É. (2012) Correlation study between sperm concentration, hyaluronic acid-binding capacity and sperm aneuploidy in Hungarian patients. Reprod Biomed Online 25, 620–626.
29. Molnar Z, Mokanszki A, Kassai Bazsane Z, Bhattoa HP, Benyo M, Olah E & Jakab A. (2014) Sperm concentration, hyaluronic acid-binding capacity, aneuploidy and persistent histones in testicular cancer. Hum Reprod 29, 1866–1874.
30. Ombelet W, Dhont N, Thijssen A, Bosmans E & Kruger T. (2014) Semen quality and prediction of IUI success in male subfertility: a systematic review. Reprod Biomed Online 28, 300–309.
31. Palomba S, Falbo A, Espinola S, Rocca M, Capasso S, Cappiello F & Zullo F. (2011) Effects of highly purified follicle-stimulating hormone on sperm DNA damage in men with male idiopathic subfertility: a pilot study. J Endocrinol Invest 34, 747–752.
32. Piomboni P, Serafini F, Gambera L, Musacchio C, Collodel G, Morgante G & De Leo V. (2009) Sperm aneuploidies after human recombinant follicle stimulating hormone therapy in infertile males. Reprod Biomed Online 18, 622–629.
33. Prinosilova P, Kruger T, Sati L, Ozkavukcu S, Vigue L, Kovanci E & Huszar G. (2009) Selectivity of hyaluronic acid binding for spermatozoa with normal Tygerberg strict morphology. Reprod Biomed Online 18, 177–183.
34. Roudebush WE, Worrilow KC, Peters AJ, Mitchell-Leef D, Shapiro DB & Massey JB. (2004) The hyaluronan binding assay (HBA™) has a positive and significant relationship with sperm morphology and chromatin integrity. Fertil Steril 82, S283–S284.
35. Ruvolo G, Roccheri MC, Brucculeri AM, Longobardi S, Cittadini E & Bosco L. (2013) Lower sperm DNA fragmentation after r-FSH administration in functional hypogonadotropic hypogonadism. J Assist Reprod Genet 30, 497–503.
36. Ruwanpura SM, McLachlan RI, Matthiesson KL & Meachem SJ. (2008) Gonadotrophins regulate germ cell survival, not proliferation, in normal adult men. Hum Reprod 23, 403–411.
37. Santi D, Granata AR & Simoni M. (2015) FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis. Endocr Connect 4, R46–R58.
38. Selice R, Garolla A, Pengo M, Caretta N, Ferlin A & Foresta C. (2011) The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. Int J Androl 34, 306–312.
39. Simoni M, Santi D, Negri L, Hoffmann I, Muratori M, Baldi E, Cambi M, Marcou M, Greither T, Baraldi E, Tagliavini S, Carra D, Lombardo F, Gandini L, Pallotti F, Krausz C, Rastrelli G, Ferlin A, Menegazzo M, Pignatti E, Linari F, Marino M, Benaglia R, Levi-Setti PE & Behre HM. (2016) Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p. N680S: a pharmacogenetic study. Hum Reprod 31, 1960–1969.
40. Sousa M, Cremades N, Alves C, Silva J & Barros A. (2002) Developmental potential of human spermatogenic cells co-cultured with Sertoli cells. Hum Reprod 17, 161–172.
41. Tournaye H, Krausz C & Oates RD. (2016a) Novel concepts in the aetiology of male reproductive impairment. Lancet Diabetes Endocrinol. Epub ahead of print. doi: 10.1016/S2213-8587(16)30040-7.
42. Tournaye H, Krausz C & Oates RD. (2016b) Concepts in diagnosis and therapy for male reproductive impairment. Lancet Diabetes Endocrinol. Epub ahead of print. doi: 10.1016/S2213-8587(16)30043-2.
43. Tüttelmann F, Laan M, Grigorova M, Punab M, Sõber S & Gromoll J. (2012) Combined effects of the variants FSHB −211G>T and FSHR 2039A>G on male reproductive parameters. J Clin Endocrinol Metab 97, 3639–3647.
44. WHO (2010) WHO Laboratory Manual for the Examination and Processing of Human Semen, 5th edn. WHO Press, Geneva, Switzerland.
45. Worrilow KC, Eid S, Woodhouse D, Perloe M, Smith S, Witmyer J, Ivani K, Khoury C, Ball GD, Elliot T & Lieberman J. (2013) Use of hyaluronan in the selection of sperm for intracytoplasmic sperm injection (ICSI): significant improvement in clinical outcomes-multicenter, double-blinded and randomized controlled trial. Hum Reprod 28, 306–314.
46. Yagci A, Murk W, Stronk J & Huszar G. (2010) Spermatozoa bound to solid state hyaluronic acid show chromatin structure with high DNA chain integrity: an acridine orange fluorescence study. J Androl 31, 566–572.